ArticleThe Lancet regional health. Europe2025

Eculizumab withdrawal and monitoring in atypical haemolytic uraemic syndrome (SETS aHUS): a multicentre, open label, prospective, single arm trial.

Andrew Bryant et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.